Surveillance and follow up outcomes of myocarditis after mRNA COVID-19 vaccination in Australia

Surveillance and follow up outcomes of myocarditis after mRNA COVID-19 vaccination in Australia

Abstract Clinical progression and medium-long term morbidity from myocarditis following mRNA COVID-19 vaccinations remains an important but undefined public health concern. We conducted prospective follow-up of individuals with either confirmed or probable myocarditis following monovalent Pfizer-Bio...

Full description

Saved in:
Bibliographic Details
Main Authors: Lucy Deng, Amanda Van Eldik, Megan O’Moore, Jim Buttery, Abigail Cheung, Nicholas Cox, Carla Drake-Brockman, Nathan Dwyer, Paul Effler, Michael Gold, Pravin Hissaria, Andrew Kelly, Sarah Khanlari, Claire Larter, Shannon Melody, Michael Nissen, Rajesh Puranik, James Rankin, Sally Singleton, Liza Thomas, Sudhir Wahi, Gavin Wheaton, Dominica Zentner, Kristine Macartney, Clara K. Chow, Nicholas Wood
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:npj Vaccines
Online Access:https://doi.org/10.1038/s41541-025-01206-w
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41541-025-01206-w

Similar Items